MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $17.55 million. The enterprise value is $13.41 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 16.56 million shares outstanding. The number of shares has increased by 9.59% in one year.
| Current Share Class | 16.56M |
| Shares Outstanding | 16.56M |
| Shares Change (YoY) | +9.59% |
| Shares Change (QoQ) | +1.97% |
| Owned by Insiders (%) | 20.84% |
| Owned by Institutions (%) | 6.76% |
| Float | 10.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.82 |
| P/TBV Ratio | 4.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.11
| Current Ratio | 6.11 |
| Quick Ratio | 5.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.16 |
Financial Efficiency
Return on equity (ROE) is -192.32% and return on invested capital (ROIC) is -91.51%.
| Return on Equity (ROE) | -192.32% |
| Return on Assets (ROA) | -81.27% |
| Return on Invested Capital (ROIC) | -91.51% |
| Return on Capital Employed (ROCE) | -241.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.75M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.75% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.75% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 45.00 |
| Average Volume (20 Days) | 385,617 |
Short Selling Information
The latest short interest is 701,873, so 4.24% of the outstanding shares have been sold short.
| Short Interest | 701,873 |
| Short Previous Month | 583,890 |
| Short % of Shares Out | 4.24% |
| Short % of Float | 6.64% |
| Short Ratio (days to cover) | 2.90 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.64M |
| Pretax Income | -12.36M |
| Net Income | -11.24M |
| EBITDA | n/a |
| EBIT | -8.64M |
| Earnings Per Share (EPS) | -$0.57 |
Full Income StatementBalance Sheet
The company has $4.14 million in cash and n/a in debt, giving a net cash position of $4.14 million or $0.25 per share.
| Cash & Cash Equivalents | 4.14M |
| Total Debt | n/a |
| Net Cash | 4.14M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 3.57M |
| Book Value Per Share | 0.22 |
| Working Capital | 3.54M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |